Northern Trust Corp Volitionrx LTD Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Volitionrx LTD stock. As of the latest transaction made, Northern Trust Corp holds 117,875 shares of VNRX stock, worth $87,227. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117,875
Previous 117,875
-0.0%
Holding current value
$87,227
Previous $70,000
4.29%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding VNRX
# of Institutions
24Shares Held
21.2MCall Options Held
0Put Options Held
0-
Lagoda Investment Management, L.P. New York, NY10.2MShares$7.54 Million3.7% of portfolio
-
Armistice Capital, LLC New York, NY8.21MShares$6.07 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA762KShares$563,8430.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA706KShares$522,4840.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$381,8940.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $42.4M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...